In particular, our US team was complemented by Anna Yanaeva, Business Development Director. Discuss with Anna your next clinical program at the following events:
‘We believe that intensification of dialogue with our US-based sponsors is a logical continuation of our business development in the region. We are convinced that the quality of our services meets the highest international standards of modern clinical trials. It is well known that high levels of service within the industry are determined by experience, knowledge and commitment to hard work. All these factors made us the biggest and the most professional CRO team in our native market’, comments OCT President Dmitry Sharov.
Please contact OCT team in Boston via phone or email: +1 857 285 0669; AYanaeva@oct-clinicaltrials.com